to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Life sciences business owners are seeing a modest rise in venture capital funds – no mean feat in this economy. But one big communications mistake will take you and your firm out of the running.
The venture capital climate improved in RTP in the first quarter, but biotech companies are still competing for dollars. Several RTP companies saw venture capital investment for development of pharmaceutical products and medical technologies. Read more to learn about the venture capital climate.
Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.
Healthcare investing by venture capitalists dropped to its lowest level in five quarters, but the decrease follows a five-quarter high. Read more for details.
It’s no secret that the economy is in sickbay. But healthcare entrepreneurs looking for a big transfusion of cash shouldn’t look to an initial public offering.
At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.
One of the questions I get asked the most is some version of "what do you think of crowdfunding?" I usually answer with some noncommittal answer about how it is going to be important, but no really knows how it will impact the trajectory and success of startup companies. After all, the notion of banding together through social media to fund the development of a prototype, documentary film or art project has been going on for many years now.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.